Webinar: The Role of Organoid Manufacturing in Advancing Drug Discovery
April 2025
In this webinar, Dr. Katie Kilgour and Hajime Onuki from the Ajinomoto Group Regenerative Medicine division discuss the latest advancements in organoid manufacturing for drug discovery.
The team covers several key concepts, including how human pluripotent stem cells (HPSCs) work and their potential for cell therapies and drug screening. They also discuss the latest research on organoids, including drug screening systems for kidney and airway organoids, emphasizing the importance of using high-quality, animal-origin-free materials for safety and efficacy. The session concludes with a summary of the Ajinomoto Group’s involvement in organoid manufacturing.
We encourage you to contact us if you have any questions, or are interested in collaborating in the Regenerative Medicine field.
The Role of Organoid Manufacturing in Advancing Drug Discovery
Meet our Speakers
Dr. Katie Kilgour
Account Manager at Ajinomoto Health & Nutrition North America, Inc.
Hajime Onuki
Technical Manager at Ajinomoto Health & Nutrition North America, Inc.
Interested in Collaborating?
We would love to hear from you! Reach out to us for more information on any of our innovation solutions or general inquiries. We look forward to chatting with you.
